1,4-bis(3-aminopropyl)piperazine derivative and its use
AssigneesInserm (Institut National De La Sante Et De La Recherche Medicale), Universite De Lille 2 Droit Et Sante
InventorsNicolas Sergeant, Luc Buee, Patricia Melnyk, Marion Gay, Nicolas Le Fur
Life of this patent
Estimating the term…
Abstract
The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.
Claims6
A method of alleviating a Tauopathy, comprising administering to a patient in need thereof a pharmaceutically effective amount of a compound of Formula I
- or a pharmaceutically acceptable salt thereof.
A method for decreasing pathological Tau protein phosphorylation in a patient in need thereof, comprising administering to said patient an effective amount of a compound of Formula I
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.